PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.52 +0.00 (+0.35%)
As of: Aug 21, 2026 · 9:45 AM EDT

PharmaCyte Biotech (PMCB) EBT Margin (QoQ) (2010 - 2012)

PharmaCyte Biotech (PMCB) EBT Margin (QoQ) (2010 - 2012) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.04 Bn 130.18 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.98 Bn 77.98 Bn 3.93 Bn
3 Argenx Se 64.37 Bn 59.19 Bn 1.37 Bn
4 Moderna 57.67 Bn 52.53 Bn 52.00 Mn
5 BeOne Medicines 41.94 Bn 36.84 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
7 BioNTech SE 27.75 Bn 9.35 Bn 668.28 Mn
8 Insmed 27.24 Bn 26.08 Bn 358.27 Mn
9 Royalty Pharma 27.03 Bn 26.20 Bn -
10 PharmaCyte Biotech 4.32 Mn 4.32 Mn -

Historic Data

Download Data
DateValue
Oct 31, 2012 220,875.00
Jul 31, 2012 30,897.00
Apr 30, 2012 -693,665.00
Jan 31, 2012 404.00
Oct 31, 2011 126,847.00
Jul 31, 2011 -243,588.00
Apr 30, 2011 -99,353.00
Jan 31, 2011 -8,903.00
Oct 31, 2010 13,758.00